IgA nephropathy: open trials in United Kingdom

10 open trials have a site in United Kingdom. Registry data; only the trial team decides who can take part.

NCT06963827
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Trial Treatment · Phase 3 · Takeda
Birmingham Heartlands Hospital, Birmingham · Kent & Canterbury Hospital, Canterbury, Canterbury · Hull University Teaching Hospitals NHS Trust, Hull · Leicester General Hospital, Leicester · St. George's University Hospitals NHS Foundation Trust, London · King's College Hospital, London · Guy's and St Thomas' NHS Foundation Trust - Guy's Hospital, London · Nottingham University Hospitals NHS Trust - City Hospital, Nottingham · Lancashire Teaching Hospital NHS Foundation Trust, Preston · Northern General Hospital, Sheffield
Registry updated 2026-11-04
NCT06989359
Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
Trial Treatment · Phase 2 · ADARx Pharmaceuticals, Inc.
Leicester · Newcastle upon Tyne
Registry updated 2026-10-20
NCT07649538
Mediators of Loin Pain in IgA Nephropathy
Research · University of Leicester
University Hospitals of Leicester, Leicester
Registry updated 2026-10-20
NCT06935357
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
Trial Treatment · Phase 3 · Biogen
Leicester General Hospital, Leicester · St Pancras Clinical Research, London · Royal Preston Hospital - NWCRN- PPDS, Preston · Northern General Hospital, Sheffield · Royal Stoke University Hospital, Stoke-on-Trent
Registry updated 2026-10-14
NCT04557462
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Cambridge · Leicester · London · Newcastle upon Tyne · Salford
Registry updated 2026-10-05
NCT07182227
PS-002 for the Treatment of IgA Nephropathy in Adults
Trial Treatment · Phase 1/2 · Purespring Therapeutics Limited
Southmead Hospital, Bristol · Cardiff and Vale University Health Board, Cardiff · Royal Infirmary of Edinburgh Clinical Research Facility, Edinburgh · Leicester General Hospital, Leicester · The Royal London Hospital, London · Manchester University NHS Foundation Trust, Manchester · Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Manchester · Nottingham University Hospitals NHS Trust, Nottingham
Registry updated 2026-09-09
NCT07054684
Study of BHV-1400 in IgA Nephropathy
Trial Treatment · Phase 1 · Biohaven Therapeutics Ltd.
Leicester
Registry updated 2026-06-23
NCT04663204
A Study of the Safety and Activity of Sparsentan for the Treatment of Patients With Immunoglobulin A Nephropathy
Trial Treatment · Phase 2 · University of Leicester
Cambridge University Hospitals NHS Trust, Cambridge · University Hospital of Wales, Cardiff · Royal Infirmary of Edinburgh & Western General Hospital, Edinburgh · Leicester General Hospital, University Hospitals of Leicester NHS Trust, Leicester · King's College Hospital, London · Northern Care Alliance NHS Foundation Trust - Salford Royal, Salford
Registry updated 2026-06-03
NCT05003986
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
Trial Treatment · Phase 2 · Travere Therapeutics, Inc.
University Hospitals Bristol and Weston NHS Foundation Trust Bristol Royal Hospital for Children, Bristol · NHS Greater Glasgow and Clyde, Royal Hospital for Children, Glasgow · Alder Hey Children's NHS Foundation Trust, Liverpool · Great Ormond Street Hospital For Children NHS Foundation Trust, London · Manchester University NHS Foundation Trust, Manchester
Registry updated 2026-05-12
NCT06065852
National Registry of Rare Kidney Diseases
Research · UK Kidney Association
Zoe Plummer, Bristol
Registry updated 2023-10-04

All IgA nephropathy trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error